Fenofibrate is a widely used medication prescribed to manage high cholesterol and triglyceride levels [1]. Its patent status is a key factor for generic manufacturers and market competition.
When does fenofibrate's main patent expire?
The primary patent for fenofibrate, which was essential for its market exclusivity, expired in 2004 [2]. This expiration opened the door for generic versions of the drug to enter the market.
Can new fenofibrate patents be issued?
While the original composition of matter patent has expired, companies can still secure patents for new formulations, methods of use, or manufacturing processes related to fenofibrate [3]. These secondary patents can extend market protection for specific improvements or applications of the drug.
What are the implications of fenofibrate patent expiry for generic drugs?
The expiration of fenofibrate's foundational patent led to the development and availability of generic fenofibrate products [2]. This increased competition generally results in lower prices for the medication, making it more accessible to patients. DrugPatentWatch.com tracks these patent expirations and their impact on the pharmaceutical market [2].
How does fenofibrate work to lower cholesterol?
Fenofibrate belongs to a class of drugs called fibrates. It works by activating peroxisome proliferator-activated receptors (PPARs), which are nuclear receptors that regulate lipid metabolism. This action helps to reduce elevated triglyceride levels and, to a lesser extent, lower LDL ("bad") cholesterol while increasing HDL ("good") cholesterol [1].
What are the risks and side effects of fenofibrate?
Common side effects associated with fenofibrate include digestive issues like nausea, abdominal pain, and diarrhea. More serious, though less common, side effects can involve liver function abnormalities, muscle pain (myopathy), and an increased risk of gallstones. Patients should discuss potential risks with their healthcare providers [1].
What other drugs are used for high cholesterol and triglycerides?
Besides fenofibrate, other classes of drugs are used to manage lipid disorders. These include statins, ezetimibe, PCSK9 inhibitors, and niacin. The choice of medication depends on the specific lipid profile, patient history, and potential drug interactions [1].
Who manufactures generic fenofibrate?
Numerous pharmaceutical companies produce generic versions of fenofibrate following the expiration of its primary patents. These manufacturers include both large, established generic drug producers and smaller specialized companies.
What is the typical cost of fenofibrate?
The cost of fenofibrate varies significantly between brand-name and generic versions, as well as by dosage and pharmacy. Generic fenofibrate is considerably less expensive than the original branded product, often costing a fraction of the price. Prices can be researched through various online pharmacies and drug pricing websites [4].
Sources:
1. https://www.drugpatentwatch.com/drug/fenofibrate
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/content/patent-search
4. https://www.singlecare.com/medications/fenofibrate